As an investor, when the company making the pitch says “We are a Class I, II and III device!” your ears should perk up immediately, because that is just not right. And never correct.
In this third clip from my RAQA Today conversation with Mitch Robbins, I share my experiences listening to investor pitches and discuss what the company making the pitch should – and should not – tell you.
Regulatory Strategy DOES Make a Difference
I have seen some VERY dysfunctional organizations in my day. No matter the size or how long the company has
Learn More
PPE, Masks and FDA Regulations in the Age of Coronavirus
Protective gear is in high demand, and it seems everyone is making masks. In this clip from Joe Hage’s weekly
Learn More
Regulatory as a Strategic Partner, Not a Necessary Evil
Many startups make the mistake of viewing regulatory affairs – and regulators – as a necessary evil, or barrier to
Learn More
Michelle Lott and the leanTeam help clients recognize regulatory and quality issues aren't a "burden" – they are strategic advantages when used properly. The expert team will also strip away any redundant or misdirected activities so you can focus on what really matters:
